Skip to content

Efficacy of premedication with melatonin versus oral midazolam in pediartic patients

Efficacy of premedication with melatonin versus oral midazolam in pediartic patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101616106N2
Enrollment
23
Registered
2016-12-27
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dental anxiety and management. Mental and behavioural disorders

Interventions

Intervention 1: "Intervention group: Oral Melatonin tablet of 3 mg was grounded and added to 1cc of sweetened drinking water before being administered an hour prior to the actual IV sedation episode."
Treatment - Drugs
"Intervention group: Oral Melatonin tablet of 3 mg was grounded and added to 1cc of sweetened drinking water before being administered an hour prior to the actual IV sedation episode."
"Control group: Oral Midazolam Vial of 5mg was added to 1cc sweetened drinking water before being administered half an hour prior to the actual IV sedation episode."

Sponsors

Vice Chancellor of Research, Shahid Beheshti University of Medical Sciences
Lead Sponsor
Vice Chancellor of Research, Shahid Beheshti University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
2 Years to 6 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Uncooperative chidren aged 2-6 years, completely negative Frankel behavioral scale approved by two pediatric dentists, ASA I for systemic health with at least two teeth requiring treatments like pulpotomy, restoration, stainless steel crown or extraction for two separate dental visits. Exclusion criteria: Any systemic disease with contraindications for sedation or premedication, cold symptoms, nasal obstruction, respiratory infection, limited neck movement, macroglossia, tonsillar hypertrophy, micrognathia, mouth opening limitation, not being able to remain NPO and having less than two teeth requiring the same treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sedation. Timepoint: At the IV Administration step. Method of measurement: Houpt scale.

Secondary

MeasureTime frame
Evaluation of recovery process and medication side effects. Timepoint: After the treatment ends and IV sedation reversed. Method of measurement: Observation and asking parents.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfshin Zarghi

Shahid Beheshti University of Medical Sciences

zarghi@sbmu.ac.ir+98 21 2243 9780

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026